Orange Book product · Generic (ANDA)
IBUPROFEN LYSINE
IBUPROFEN LYSINE
Generic (ANDA)ANDA 202402TE APRX XGEN PHARMS
At a glance
Mar 30, 2016
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 30, 2016
10 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
IBUPROFEN LYSINE
Strength
EQ 20MG BASE/2ML (EQ 10MG BASE/ML)
Dosage form
INJECTABLE
Route
INTRAVENOUS
TE code
AP
Application
ANDA 202402
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of IBUPROFEN LYSINE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
